.png){kind=icon}
.png){kind=icon}
Return
A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for Heart Failure with Reduced Ejection Fraction: NET-COST-HFrEF
.png){kind=icon}
OA
AI
R
E
B
V
D
R
D
K
P
C
C
R
R
P
J
G
DOI：10.1093/ejhf/xuag233.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
To assess the cost-effectiveness of guideline-directed medical treatments for heart failure with reduced ejection fraction (HFrEF) by performing a network meta-analysis (NMA) of randomized controlled trials (RCTs) feeding a subsequent cost-effectiveness analysis.
Journal
IF:
10.8
Papers:
6.6K
Citations:
2.1W
Organization
Cited Papers